{"id":394350,"date":"2020-12-07T09:03:16","date_gmt":"2020-12-07T14:03:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=394350"},"modified":"2020-12-07T09:03:16","modified_gmt":"2020-12-07T14:03:16","slug":"musclepharm-hires-icr-inc-as-investor-relations-advisor","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/","title":{"rendered":"MusclePharm Hires ICR Inc. as Investor Relations Advisor"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CALABASAS, Calif., Dec.  07, 2020  (GLOBE NEWSWIRE) &#8212; MusclePharm Corporation (OTCMKTS: MSLP) (the \u201cCompany\u201d), a global provider of leading sports nutrition &amp; lifestyle branded nutritional supplements, today announced that the Company has retained ICR, Inc., a leading strategic communications and advisory firm, to assist with its investor relations program.<\/p>\n<p align=\"justify\">Ryan Drexler, President and Chief Executive Officer, stated, \u201cWe are very excited to be working with a distinguished communications firm like ICR to build out our investor relations program and help position our Company. The past few years have been spent restructuring the Company and strengthening our leading brands and we believe ICR will be instrumental in broadening our reach with the investment community and increasing our public profile with shareholders.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About <\/strong><br \/>\n        <strong>MusclePharm<\/strong><br \/>\n        <strong>, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">MusclePharm\u00ae is an award-winning, worldwide leading sports nutrition &amp; lifestyle company offering branded nutritional supplements. Its portfolio of recognized properties include the MusclePharm\u00ae Sport Series, Essentials Series, Natural Series, and FitMiss\u2122 \u2013 a product line designed specifically for female athletes. MusclePharm\u00ae products are available in more than 100 countries globally, with its Combat Protein product lineup being the company\u2019s most popular.<\/p>\n<p align=\"justify\">\n        <strong>About ICR, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Established in 1998, ICR partners with its clients to execute strategic communications and advisory programs that achieve business goals, build awareness and credibility, and enhance long-term enterprise value. The firm\u2019s highly-differentiated service model, which pairs capital markets veterans with senior communications professionals, brings deep sector knowledge and relationships to more than 750 clients in approximately 20 industries. ICR\u2019s healthcare practice operates under the Westwicke brand (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tZ_5wLHbudlVCWvibLSjF3-vyUDjjTXmJCbW2uLzpbPHTzoawGF8WQ575TUkMdI1Pp4MoGW0iGxyoO39MMcURA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.westwicke.com<\/a>). Today, ICR is one of the largest and most experienced independent communications and advisory firms in North America, maintaining offices in New York, Norwalk, Boston, Baltimore, San Francisco, San Diego and Beijing. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y9WyZMQe_WiSMWAX9-U_8cbnBuUMBKe0SQ8qgd_84QpHkZfk9551Q4dTnXTpWbzzPfWp7uHVZp-a-eetIpOONA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.icrinc.com<\/a>. Follow us on Twitter at @ICRPR.<\/p>\n<p align=\"justify\">\n        <strong>FORWARD-LOOKING STATEMENTS:<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements, such as those regarding ICR\u2019s expected impact on the Company\u2019s profile with shareholders and the investment community, within the meaning of the Private Securities Litigation Reform Act of 1995.\u00a0 All statements, other than statements of historical facts, regarding MusclePharm\u2019s expectations, strategies, prospects or targets are forward-looking statements.\u00a0 These forward-looking statements also can be identified by the use of forward-looking terminology such as \u201canticipates,\u201d \u201cbelieves,\u201d \u201ccontinues,\u201d \u201ccould,\u201d \u201cestimates,\u201d \u201cexpects,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpredict,\u201d \u201cproject,\u201d or \u201cwill,\u201d or the negative of these terms or other comparable terminology.\u00a0\u00a0<\/p>\n<p align=\"justify\">These forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties that could cause our actual results to differ materially from those projected including: the duration of the COVID-19 pandemic and the extent and length of the shelter-in and other restrictions associated with COVID-19 pandemic.<\/p>\n<p align=\"justify\">Forward-looking statements are made only as of the date hereof.\u00a0 Except as otherwise required by law, we assume no obligation to update any of the forward-looking statements contained in this press release.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong><br \/>\n        <br \/>John Mills, Managing Partner<br \/>ICR, Inc.<br \/>646-277-1254<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=faBTr_M9q2OUtaHjuudnurEK820_J2xRxKv61RDaraWalVc-QQ2Y1EBsbyApd7ZWhdoYL0WtO8Q5zMNnNitJta35hjWkDtJ_1txqB594Ie8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">John.Mills@Icrinc.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/05064be5-d871-41e8-91ea-ddf2db1c209e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CALABASAS, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; MusclePharm Corporation (OTCMKTS: MSLP) (the \u201cCompany\u201d), a global provider of leading sports nutrition &amp; lifestyle branded nutritional supplements, today announced that the Company has retained ICR, Inc., a leading strategic communications and advisory firm, to assist with its investor relations program. Ryan Drexler, President and Chief Executive Officer, stated, \u201cWe are very excited to be working with a distinguished communications firm like ICR to build out our investor relations program and help position our Company. The past few years have been spent restructuring the Company and strengthening our leading brands and we believe ICR will be instrumental in broadening our reach with the investment community and increasing our public profile with shareholders.\u201d &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MusclePharm Hires ICR Inc. as Investor Relations Advisor&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-394350","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MusclePharm Hires ICR Inc. as Investor Relations Advisor - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MusclePharm Hires ICR Inc. as Investor Relations Advisor - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CALABASAS, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; MusclePharm Corporation (OTCMKTS: MSLP) (the \u201cCompany\u201d), a global provider of leading sports nutrition &amp; lifestyle branded nutritional supplements, today announced that the Company has retained ICR, Inc., a leading strategic communications and advisory firm, to assist with its investor relations program. Ryan Drexler, President and Chief Executive Officer, stated, \u201cWe are very excited to be working with a distinguished communications firm like ICR to build out our investor relations program and help position our Company. The past few years have been spent restructuring the Company and strengthening our leading brands and we believe ICR will be instrumental in broadening our reach with the investment community and increasing our public profile with shareholders.\u201d &hellip; Continue reading &quot;MusclePharm Hires ICR Inc. as Investor Relations Advisor&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T14:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MusclePharm Hires ICR Inc. as Investor Relations Advisor\",\"datePublished\":\"2020-12-07T14:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/\"},\"wordCount\":491,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/\",\"name\":\"MusclePharm Hires ICR Inc. as Investor Relations Advisor - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=\",\"datePublished\":\"2020-12-07T14:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/musclepharm-hires-icr-inc-as-investor-relations-advisor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MusclePharm Hires ICR Inc. as Investor Relations Advisor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MusclePharm Hires ICR Inc. as Investor Relations Advisor - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/","og_locale":"en_US","og_type":"article","og_title":"MusclePharm Hires ICR Inc. as Investor Relations Advisor - Market Newsdesk","og_description":"CALABASAS, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; MusclePharm Corporation (OTCMKTS: MSLP) (the \u201cCompany\u201d), a global provider of leading sports nutrition &amp; lifestyle branded nutritional supplements, today announced that the Company has retained ICR, Inc., a leading strategic communications and advisory firm, to assist with its investor relations program. Ryan Drexler, President and Chief Executive Officer, stated, \u201cWe are very excited to be working with a distinguished communications firm like ICR to build out our investor relations program and help position our Company. The past few years have been spent restructuring the Company and strengthening our leading brands and we believe ICR will be instrumental in broadening our reach with the investment community and increasing our public profile with shareholders.\u201d &hellip; Continue reading \"MusclePharm Hires ICR Inc. as Investor Relations Advisor\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-07T14:03:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MusclePharm Hires ICR Inc. as Investor Relations Advisor","datePublished":"2020-12-07T14:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/"},"wordCount":491,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/","name":"MusclePharm Hires ICR Inc. as Investor Relations Advisor - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=","datePublished":"2020-12-07T14:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzUwMSMzODU4NTc4IzIyMDU1MzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/musclepharm-hires-icr-inc-as-investor-relations-advisor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MusclePharm Hires ICR Inc. as Investor Relations Advisor"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=394350"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394350\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=394350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=394350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=394350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}